Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.31 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2971426 | 0.95 | NR1H2 (0.32) | NR1H2NR1H3LIPGTLR8 | |
| SCHEMBL2972056 | 0.80 | HSD11B1 (0.38) | — | |
| SCHEMBL2961866 | 0.78 | PPARA (0.33) | NR1H2NR1H3 | |
| SCHEMBL2967735 | 0.77 | GPR3 (0.32) | NR1H2NR1H3LIPG | |
| SCHEMBL2962115 | 0.77 | NR1H2 (0.32) | NR1H2NR1H3LIPGTLR8 | |
| SCHEMBL2959220 | 0.77 | NR1H2 (0.32) | NR1H2NR1H3LIPGTLR8 | |
| SCHEMBL2975448 | 0.76 | PPARA (0.31) | NR1H2NR1H3LIPG | |
| SCHEMBL2972127 | 0.76 | NR1H2 (0.31) | NR1H2NR1H3LIPG | |
| SCHEMBL2973785 | 0.75 | NR1H2 (0.32) | NR1H2NR1H3LIPG | |
| SCHEMBL2966342 | 0.74 | NR1H2 (0.32) | NR1H2NR1H3LIPGTLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7763562-B2 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-07-27 | — | — | US | disclosed |
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135597-A1 | Heteroatom bridged metallocene compounds for olefin polymerization | AP2M1, AP1M1, PYM1 | NR1H2 1227/4885NR1H3 1012/4885LIPG 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.